Navigation Links
Quincy Bioscience Sponsors Multiple Sclerosis (MS) Scholarship Program
Date:6/17/2010

Quincy Bioscience is pleased to be a sponsor of the annual fundraising MS Luncheons held in Wisconsin which help support families affected by MS and to be a corporate contributor to the MS Scholarship Program. Quincy Bioscience recently launched MS HOPE Trials which will investigate how its patented calcium-binding technology may help improve the quality of life for those with MS.

Madison, WI (Vocus) June 17, 2010 -- Quincy Bioscience is pleased to be a sponsor of the annual MS Luncheons held in Milwaukee and Madison and to be a corporate contributor to the MS Scholarship Program. The MS Luncheon is an annual fundraising event which showcases how donor support moves research forward and meets urgent needs in Wisconsin.

Quincy Bioscience has recently launched the MS HOPE Trial investigating how its patented calcium-binding technology may help improve the quality of life for those with MS at MS HOPE Trials.

The theme of the luncheon fundraisers is “My Cause. My Cure. My Commitment…to a world free of MS.” Funds raised through the luncheon support ground-breaking research into the cause, care and cure of MS, and services designed to address the challenges of living with MS.

The MS Scholarship Program was created to assist in making college dreams a reality for people with MS or their children, who are pursuing a post-secondary education and have demonstrated leadership, academic excellence and financial need.

“Living with MS can be incredibly challenging. The MS Luncheons create awareness and help support those diagnosed with MS as well as their families. Quincy Bioscience is working diligently to improve the outcomes of those with Multiple Sclerosis,” explains Mark Underwood, President of Quincy Bioscience.

About Quincy Bioscience
Quincy Bioscience is a biotechnology company based in Madison, Wisconsin. Quincy Bioscience is focused on the discovery, development and commercialization of novel compounds to fight the aging process. The company's products focus on restoring calcium balance related to neurodegenerative disorders and other destructive age-related mechanisms.

###

Read the full story at http://www.prweb.com/releases/multiplesclerosis/hopetrials/prweb4152014.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Quincy Bioscience Launches HOPETrials.com; Research Studies More Accessible For Participants
2. Martek Biosciences Chief Scientific Officer, Dr. Norman Salem, 2010 Recipient of Alex Leaf Distinguished Scientist Award
3. Martek Biosciences and the National Center for Creative Aging Introduce New Brain Health Awareness Campaign, "Beautiful Minds: Finding Your Lifelong Potential"
4. Exalenz Bioscience Expands Market Coverage for the BreathID Breath Test System
5. Digital Pathology Services Firm Flagship Biosciences Appoints New CEO
6. Southridge LLC Provides Equity Capital Through Private Agreement with PuraMed Bioscience
7. Euthymics Bioscience Collaborates with GlobalSign and SafeNet to Provide an FDA Approved Electronic Signature Solution
8. Neurocrine Biosciences Announces Conference Call and Webcast to Present Fourth Quarter and Year-End 2009 Financial Results
9. Synomics Pharma and Bioscience Laboratories Announce Partnership to Provide Topical Clinical Phase 1 Study Services
10. Therapure Biopharma Inc. and YM BioSciences Inc. Announce Partnership
11. Thriving Bioscience Region Leaves Its Mark
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Quincy Bioscience Sponsors Multiple Sclerosis (MS) Scholarship Program
(Date:10/13/2017)... ... 13, 2017 , ... “America On The Brink”: the Christian history of the ... is the creation of published author, William Nowers. Captain Nowers and his wife, ... he spent thirty years in the Navy. Following his career as a naval ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has ... today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, every formula ... the highest standard. , These products are also: Gluten Free, Non-GMO, Vegan, ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... delivery system that we intend to develop to enable prevention of a major ... to severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss is ...
(Date:10/12/2017)... FL (PRWEB) , ... October 12, 2017 , ... On ... holding a treadmill relay – Miles by Moonlight to raise money for the American ... $300 or more. , Teams will work together to keep their treadmills moving ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... in wound care advancements to physician colleagues, skilled nursing facility medical directors and ... the Treacherous Waters of Wound Care." , "At many of these conferences we ...
Breaking Medicine News(10 mins):
(Date:10/10/2017)... -- NDS received FDA 510(k) clearance in May 2017 for its highly ... designed for endoscopy environments. An innovative secondary monitor solution, ZeroWire ... support the improvement of patient outcomes, procedural efficiency, and the lowering ... ... ...
(Date:10/4/2017)... 4, 2017  South Korean-based healthcare product Development Company ... "cprCUBE" on Kickstarter. The device will educate the user ... with better efficiency compared to the dated and pricey ... on efficacy of the compression for a more informed ... goal to raise $5,000. ...
(Date:10/2/2017)... Oct. 2, 2017  Eli Lilly and Company (NYSE: ... for the third quarter of 2017 on Tuesday, October ... on that day with the investment community and media ... The conference call will begin at 9 a.m. Eastern ... a live webcast of the conference call through a ...
Breaking Medicine Technology: